MiMedx Group MDXG Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 82.6%-0.2pp | 82.8%-0.2pp | 83%+1.0pp | 82%-1.7pp | |
| Operating margin | 15.3%-1.6pp | 16.9%+5.3pp | 11.5%— | —— | |
| Net margin | 11.6%-0.6pp | 12.2%-6.0pp | 18.1%+29.4pp | -11.3%— | |
| Returns | |||||
| Return on equity | 21.6%-3.7pp | 25.3%— | —— | —— | |
| Return on invested capital | 41.4%+3.1pp | 38.2%— | —— | —— | |
| Efficiency | |||||
| Asset turnover | 1.4×0.0× | 1.4×-0.2× | 1.6×+0.1× | 1.5×+0.2× | |
| Liquidity | |||||
| Current ratio | 4.3×+0.1× | 4.2×+0.6× | 3.6×+0.5× | 3.1×-0.4× | |
| Leverage | |||||
| Debt-to-equity | 0.1×0.0× | 0.1×-0.2× | 0.4×— | —— | |
| Net debt / EBITDA | -1.8×-0.6× | -1.2×-0.5× | -0.8×— | —— | |
| Per Share | |||||
| Book value per share | $1.71+32.3% | $1.30+32.5% | $0.98+714% | -$0.16-22,857% | |
| Valuation | |||||
| Market capitalization | $567.48M-33.9% | $1.41B+10.1% | $1.28B+306% | $316M-53.3% | |
| Price / earnings | 18.5×-2.9× | 33.3×+11.3× | 22×— | —— | |
| Price / sales | 1.5×-1.0× | 4.1×+0.1× | 4×+2.8× | 1.2×-1.6× | |
| Price / book | 2.3×-1.9× | 7.3×-1.7× | 9×— | —— | |
| EV / EBITDA | 8.3×-4.1× | 20.6×-10.4× | 30.9×— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are MiMedx Group's profit margins?
- MiMedx Group (MDXG) runs a 81.0% gross margin and a 10.2% operating margin, with a 7.9% net margin.
- Where do MiMedx Group's ratios come from?
- Every ratio is computed from MiMedx Group's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
